Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Study participants who received Libtayo had a 31% lower risk of death than those treated with chemotherapy.
While researchers try to figure out whether treating early anal tissue changes can prevent cancer, some are investigating treatments.
Mutations can affect how viruses behave and how well drugs and vaccines work.
COVID-19, FDA drug approvals and new approaches to treatment and quality of life stood out among this year’s top stories.
Compared with unvaccinated women, the risk among women vaccinated before age 17 dropped by almost 90%.
New guidelines assert that cervical cancer is best detected by a human papillomavirus test, but some groups disagree.
The American Cancer Society now calls for vaccination of girls and boys starting at age 9.
Women who are uninsured or can’t get regular medical care are more likely to miss out on lifesaving screening.
Human papillomavirus, which causes genital warts and various cancers, is preventable with a vaccine.
This makes a big difference in preventing the more than half a million new cervical cancer cases and over 300,000 deaths globally each year.
Or, how we know herpes doesn’t cause cervical cancer — and HPV does
A new study points to need for greater efforts to reduce racial disparities in cancer survival and increase access to health care.
Available vaccines offer protection against cervical, anal, oral, liver and stomach cancers.
Today, women between ages 30 and 65 can be offered an HPV test along with the Pap test, or an HPV test alone.
Oral STIs include chlamydia, gonorrhea, herpes simplex and human papillomavirus.
This finding may reflect higher rates of sexually transmitted infections such as HPV and hep B as well as lifestyle factors.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.